Investigators used serum fusion transcripts to assess the risk of hepatocellular carcinoma (HCC) and the impact of cancer treatment through machine learning. Credit: The American Journal of Pathology Early diagnosis of hepatocellular carcinoma (HCC)—one of the most fatal malignancies—is crucial to improve patient survival. In a breakthrough study investigators report on the development of a serum fusion-gene machine-learning model. This important screening tool may increase the five-year survival rate of patients with HCC from 20% to 90% because of its improved accuracy in early diagnosis of HCC and monitoring the Read More